Pages Menu
Categories Menu

Posted by on May 8, 2017 in Tell Me Why |

Where Would You Catch Malaria?

Where Would You Catch Malaria?

The most likely places to catch malaria would be in tropical and sub-tropical countries, especially in the forested parts of Central and South America, Central Africa, Asia, and Southern Europe. This is because the female anopheles mosquito, whose bite transmits the disease, breeds in the warm, stagnant, marshy pools found in those parts.

In 2015, there were 296 million cases of malaria worldwide resulting in an estimated 731,000 deaths. Approximately 90% of both cases and deaths occurred in Africa. Rates of disease have decreased from 2000 to 2015 by 37%, but increased from 2014 during which there were 198 million cases.

Malaria is commonly associated with poverty and has a major negative effect on economic development. In Africa, it is estimated to result in losses of US$12 billion a year due to increased healthcare costs, lost ability to work, and negative effects on tourism.

Malaria is said to derive its name from the Italian for “evil air”. It causes chills, fever and anaemia, and is sometimes fatal. In India a million people are likely to die from it every year. Malaria is a mosquito-borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single-celled microorganisms) belonging to the Plasmodium type. Malaria causes symptoms that typically include fever, feeling tired, vomiting, and headaches.

In severe cases it can cause yellow skin, seizures, coma, or death. Symptoms usually begin ten to fifteen days after being bitten. If not properly treated, people may have recurrences of the disease months later. In those who have recently survived an infection, re-infection usually causes milder symptoms. This partial resistance disappears over months to years if the person has no continuing exposure to malaria.

The disease is most commonly transmitted by an infected female Anopheles mosquito. The mosquito bite introduces the parasites from the mosquito’s saliva into a person’s blood. The parasites travel to the liver where they mature and reproduce. Five species of Plasmodium can infect and be spread by humans. Most deaths are caused by P. falciparum because P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.

The species P. knowlesi rarely causes disease in humans. Malaria is typically diagnosed by the microscopic examination of blood using blood films, or with antigen-based rapid diagnostic tests. Methods that use the polymerase chain reaction to detect the parasite’s DNA have been developed, but are not widely used in areas where malaria is common due to their cost and complexity.

The first effective remedy for it, quinine, was used in the 16th Century. It is an infusion from the bark of the cinchona tree. Modern drugs, too, have greatly reduced the threat of malaria. In particular the use of sprays on the mosquitoes’ breeding places has been highly effective. In 1955 the World Health Organization started a mosquito-eradication programme of benefit to nearly 1,200 million people.

The risk of disease can be reduced by preventing mosquito bites through the use of mosquito nets and insect repellents, or with mosquito control measures such as spraying insecticides and draining standing water. Several medications are available to prevent malaria in travellers to areas where the disease is common.

Occasional doses of the combination medication sulfadoxine/pyrimethamine are recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria. Despite a need, no effective vaccine exists, although efforts to develop one are ongoing. The recommended treatment for malaria is a combination of antimalarial medications that includes an artemisinin. The second medication may be either mefloquine, lumefantrine, or sulfadoxine/pyrimethamine.

Quinine along with doxycycline may be used if an artemisinin is not available. It is recommended that in areas where the disease is common, malaria is confirmed if possible before treatment is started due to concerns of increasing drug resistance.

Resistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.

Content for this question contributed by Leigh Garrett, resident of Burlington, Boone County, Kentucky, USA